Home
Conditions
Paramyxoviridae Infections

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

NCT00969436

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Chennai, India

GSK Investigational Site Goā, India

GSK Investigational Site Kolkata, India

View Trial Details

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

NCT00751348

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bucheon-si, South Korea

GSK Investigational Site Daejeon, South Korea

GSK Investigational Site Gwangju, South Korea

GSK Investigational Site GyeongSangNam-do, South Korea

View all 13 locations

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

NCT02058563

Conditions: Infections, Measles, Mononegavirales Infections, +14 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Miami, Florida, United States

View all 17 locations

View Trial Details

Completed

Safety Study of Oral BTA9881 to Treat RSV Infection

NCT00504907

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Nucleus Network Melbourne, Victoria, Australia

View Trial Details

Completed

A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study

NCT03382431

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: hVIVO Services Ltd London, United Kingdom

View Trial Details

Completed

Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

NCT00420966

Conditions: Behavior, Health Behavior, Infections, +10 more
Locations: Alberta Children's Hospital Calgary, Alberta, Canada

McMaster Children's Hospital Hamilton, Ontario, Canada

View Trial Details

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

NCT00432042

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +53 more
Locations: Alsfeld, Germany

Bad Saulgau, Germany

Bad Säckingen, Germany

Bad Sobernheim, Germany

View all 50 locations

View Trial Details

Completed

Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial

NCT02904642

Conditions: Infections, Measles, Mononegavirales Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

NCT02158364

Conditions: Infections, Measles, Measles/Rubella, +8 more
Locations: Osaka, Japan

View Trial Details

Completed

Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age

NCT02952339

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Center for Immunization Research Baltimore, Maryland, United States

Center for Immunization Research South Laurel, Maryland, United States

View Trial Details

Paramyxoviridae Infections

Paramyxoviridae Infections trial results

Related conditions